Archive for category: Useful Information

You are here: / / Useful Information

COVID Shots Increase Risk Of Cancer

COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province

Cecilia Acuti Martellucci 1, Angelo Capodici 1, Graziella Soldato 2, Matteo Fiore 1, Enrico Zauli 3, Roberto Carota 2, Marco De Benedictis 2, Graziano Di Marco 2, Rossano Di Luzio 2, Maria Elena Flacco 4, Lamberto Manzoli 1

This study was done in the province of Pescara, Italy involving about 300,000 residents. It was conducted from June 2021 through December 2023 and published in July 2025. It is consistent with other reports over the past few years showing an increased risk for cancer from COVID shots. Here are some of its findings.

Overall cancer risk increased 23% (HR 1.23, 95% CI 1.11-1.37).

Breast cancer risk increased 54% (HR 1.54, 95% CI 1.10-2.26).

Bladder cancer risk increased 62% (HR 1.62, 95% CI 1.07-2.445).

Colon-rectum cancer risk increased 35% (HR 1.35, 95% CI 1.01-1.80).

The following cancers had increased risk with COVID shots but were not statistically significant: hematological, uterine, ovarian, thyroid, and prostate.

https://pubmed.ncbi.nlm.nih.gov/40881928

In a previous study published in 2024, Akkus et al demonstrated a link between the COVID shots and colon cancer.

Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer

Erman Akkus 1,✉, Bahar Karaoglan 1, Cihangir Akyol 2, Ali Ekrem Ünal 3, Mehmet Ayhan Kuzu 2, Berna Savaş 4, Güngör Utkan 1

In particular, the authors studied microsatellite instability-high (MSI-H) colon cancer, named because of the instability of the tumors cells due to genetic mutations. The study ran from June 2021 through June 2023 and was published in June 2024. Two COVID shots were used: Pfizer and CoronaVac. CoronaVac was an inactivated SARS-CoV-2 virus vaccine developed in China and available to several countries during the pandemic including Turkey.

The Pfizer shot was associated with a greater than 500% increased risk of developing MSI-H colon cancer (OR 6.39, 95% CI 1.55-26.26, p = 0.01).

No such increased risk was found with CoronaVac.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11227084

Finally, there is a recently published paper by Marik et al, COVID-19 mRNA-Induced “Turbo Cancers”. How do these shots cause cancer? The authors review the mechanisms involved. At the end of the paper, they offer suggestions for preventative measures.

https://journalofindependentmedicine.org/articles/v01n03a02

/by

COVID-19 Shots and Neuropsychiatric Conditions

Association Between COVID-19 Vaccination and Neuropsychiatric Conditions James A Thorp, MD 1, Claire Rogers, MSPAS, PA-C *2, Kirstin Cosgrove, CCRA 3 Steven Hatfill, MD M Med 4, Peter Breggin, MD 5, Drew Pinsky, MD 6, Peter A McCullough, MD, MPH 7

This study collected data from the CDC, FDA and VAERS database from 1990 through 2024. It was published in June 2025. Its findings are alarming to say the least. It used Proportional Reporting Ratios (PRRs) to compare numbers of Adverse Events reports after COVID shots with reports after influenza vaccinations and total vaccinations. A PRR of 1 means the number of reports were equal with both drugs. A PRR of 2 means there were twice as many reports in the study drug compared to the comparison drug. The CDC and FDA define a PRR of 2 or greater as the safety threshold to investigate a potential danger in the study drug.

ALL of the following Adverse Events had a PRR of far greater than 2. As you can see, many were greater than 100 (100 times as many reports compared to the comparison drug).

Multiple other studies have demonstrated the same catastrophic results.

https://pubmed.ncbi.nlm.nih.gov/39560882

https://pubmed.ncbi.nlm.nih.gov/38806183

https://pubmed.ncbi.nlm.nih.gov/38834668

Yes, COVID was a stressful time. But stress is not the primary reason our neurologists, psychiatrists, and psychologists have been so busy these past 5 years…

https://ijirms.in/index.php/ijirms/article/view/2090

/by

Strokes and A Fib are side effects of COVID Shots

COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes Claire Rogers 1,*, James A Thorp 2,3, Kirstin Cosgrove 4 and Peter A McCullough 5

https://www.ijirms.in/index.php/ijirms/article/view/1982

This study used data from CDC, FDA, and VAERS databases from 1990 through 2023. It compared reports of Adverse Events after COVID shots compared to those after influenza vaccines and to all other vaccines. It did this by using Proportional Reporting Ratio (PRR). PRRs are a statistical measure to help detect whether a specific adverse event from one drug is reported more often compared to another. It is commonly used to identify potential safety signals. A PRR of 1 means the Adverse Event was reported at the same rate for both drugs. A PRR of 2 means the Adverse Event was reported twice as often in the subject drug compared to the comparison drug. Indeed, a PRR of 2 is the usual cut off to trigger a safety signal.

Cerebral Venous Thrombosis was reported 2000 times more often after COVID shots compared to influenza vaccinations (PRR 2070: 95% CI, 955-4490, p < 0.0001).

Cerebral Arterial Thrombosis was reported 1000 times more often after COVID shots compared to influenza vaccinations (PRR 1120: 95% CI, 152-8280, p < 0.0001).

Total Cerebral Thrombosis was reported 1000 times more often after COVID shots compared to influenza vaccinations (PRR 1120: 95% CI, 723-1730, p < 0.0001).

Atrial fibrillation was reported 100 times more often after COVID shots compared to all other vaccines (PRR 123: (95% CI, 88.3-172, p << 0.0001).

Further, the “Pfizer post-marketing analysis done from December 10, 2020 to February 28, 2021 [documented] 42,086 casualties including 1223 deaths in just the first 10 weeks of rollout.”*

*BNT162b2 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021. Report prepared by Worldwide Safety Pfizer for the Federal Drug Administration and approved on April 30, 2021.https://phmpt.org/wp- content/uploads/2021/11/5.3.6-postmarketing-experience.pdf. (Accessed June 15, 2023).

By the way, this 10 week analysis is part of the Pfizer data that the FDA requested to stay sealed for 75 years. Well, they lost that lawsuit and in January 2022 a federal judge ruled that the FDA must expedite the release of these documents.

https://www.ijirms.in/index.php/ijirms/article/view/1982

/by

POTS – Postural Orthostatic Tachycardia Syndrome, Myocarditis & COVID Shots

Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection Alan C. Kwan 1 , Joseph E. Ebinger 1, Janet Wei1, Catherine N. Le2, Jillian R. Oft2, Rachel Zabner2, Debbie Teodorescu1, Patrick G. Botting1, Jesse Navarrette1, David Ouyang 1, Matthew Driver1, Brian Claggett3, Brittany N. Weber3, Peng-Sheng Chen1 & Susan Cheng 1

This study was done in Los Angeles and Boston in 2022 and involved 284,592 vaccinated patients. Patients received Pfizer (62%), Moderna (31%), or Johnson & Johnson (6.9%) [less than 0.1% received another product such has AstraZeneca or Novavax]. They compared medical diagnoses that occurred within 90 days after vaccination compared to the 90 days before vaccination. The three diagnoses that had the highest post-vaccination odds were myocarditis, dysautonomia, and POTS.

Myocarditis risk increased by 157% [OR 2.57 (95% CI: 1.02-6.77, p = 0.046)].

Dysautonomia risk increased by 124% [OR 2.24 (95% CI: 1.30-3.87, p = 0.002)].

POTS risk increased by 52% [OR 1.52 (95% CI: 1.36-1.71, p < 0.001)].

Note the gender differences. Myocarditis was more common in males. POTS was more common in females.

https://pubmed.ncbi.nlm.nih.gov/37303827

/by

Increased Risk of Heart Attack, Stroke, and Arrhythmia Following COVID Shots

COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks Karimi, Raheleh1,2; Norozirad, Mina3; Esmaeili, Foad4; Mansourian, Marjan2,5; Marateb, Hamid R.6,7,8 International Journal of Preventive Medicine 16():14, March 2025. | DOI: 10.4103/ijpvm.ijpvm_260_24

This was a large meta-analysis reviewing 15 studies involving about 85 million people (45 million vaccinated, 40 million unvaccinated) from multiple countries across Asia, Europe, and North America. It was published in March 2025. Few controlled Moderna studies were available, so this study focused on the Pfizer (BNT162b2) and Astra Zeneca (ChAdOx1) shots.

Figure 4: Subgroup analysis for arrhythmia, MI, CVD, and Stroke events following COVID-19 vaccination

Karimi, Raheleh1,2; Norozirad, Mina3; Esmaeili, Foad4; Mansourian, Marjan2,5; Marateb, Hamid R.6,7,8

COVID shots increased the risk of the following events/diseases:

Coronary Artery Disease (CAD)

Overall: 70% increased risk [OR 1.70 (95% CrI: 1.11-2.57)]

Pfizer: 64% increased risk [OR 1.64 (95% CrI: 1.06-2.55)]

2nd dose all vaccines: 244% increased risk [OR 3.44 (95% CrI: 1.99-5.98)]

Myocardial Infarction (MI)

2nd dose all vaccines: 286% increased risk [OR 3.86 (95% CrI: 2.28-6.60)]

Pfizer: 87% increased risk [OR 1.87 (95% CrI: 1.22-2.89)]

Pfizer 2nd dose: 284% increased risk [OR 3.84 (95% CrI: 2.21-6.66)]

Stroke

Pfizer: 109% increased risk [OR 2.09 (95% CrI: 1.36-3.21)]

Pfizer 1st dose: 269% increased risk [OR 3.69 (95% CRI: 2.13-6.37)]

All vaccines 1st dose: 240% increased risk [OR 3.40 (95% CrI: 1.98-5.86)}

Arrhythmia

All vaccines 1st dose: 199% increased risk {OR 2.99 (95% CrI: 1.20-7.44)]

AZ: 711% increased risk [OR 8.11 (95% CrI: 3.67-17.99)]

AZ 1st dose: 389% increased risk [OR 4.89 (95% CRI: 1.21-19.38)]

How can anyone look at this data and say the COVID shots are safe? They are not safe. They are dangerous and they are deadly…

https://pubmed.ncbi.nlm.nih.gov/40191438

/by

Autopsy Findings & COVID Shots

A review study was done in 2023, analyzing all published autopsies related to COVID-19 vaccination. In total 44 papers representing 325 autopsy cases were studied.

The most implicated organ system was the cardiovascular system (49%).

Most deaths occurred within a week from last shot administration.

240 deaths (73.9%) were independently adjudicated as directly due to or significantly contributed to by the COVID shots.

The primary causes of death included: cardiac (35%), pulmonary embolism (12.5%), myocardial infarction (12%), VITT (7.9%), myocarditis (7.1%), multisystem inflammatory syndrome (4.6%), and cerebral hemorrhage (3.8%).

A Systematic Review Of Autopsy Findings In Deaths After COVID-19 Vaccination
/by

Mortality & COVID Shots

openvaers.com/covid-data/mortality

VAERS is the vaccine adverse event reporting system managed by the CDC and FDA. It is a voluntary reporting system, thus its numbers grossly underestimate the true number. Case reports are carefully vetted by the CDC before they are added to the database. Submitting a false report is against federal law, a felony, and punishable by fine and imprisonment. As you can see the total number of reports of death associated with vaccination was quite low for many years – until 2021. No previous vaccine has ever been associated with nearly as many deaths as the COVID shots. Indeed, the COVID shots have resulted in more reports of death than all other vaccines combined.

/by

AAP Defies The CDC

Earlier this year, the Centers for Disease Control and Prevention (CDC) removed COVID shot recommendations for all healthy children. Well, just this week the American Academy of Pediatrics (AAP) rejected this recommendation and advised COVID shots for all children 6 months and older. What’s going on here? I didn’t think you were allowed to reject CDC guidelines, especially guidelines about COVID. Why the discrepancy? Hmm…? Sometimes sense can be made by following the money. According to AAP’s own website, their top corporate sponsors are Merck, Sanofi, Moderna, and Pfizer…

/by

The Pediatric Study From the CDC

[Note: If you want to read the series about COVID shot effectiveness in chronological order, please start with, “The Truth About The COVID Shots,” posted on August 11, 2025.]

This one is interesting because it was a pediatric study done by the CDC in conjunction with medical institutions in Washington, Oregon, Michigan, Arizona, and Utah.  It’s called Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months – 4 years, United States, September 2022-April 2023.  Even though the study period ended in early 2023, the paper was not published until January 2025. 

First, it showed that natural immunity is effective protection from infection.  “Participants with evidence of prior SARS-CoV-2 infection were less likely to be infected with SARS-CoV-2 and experience symptomatic COVID-19 compared with those who had no evidence of prior infection (HR: 0.21 [95% CI: 0.08-0.54]).”  This amounts to a 79% reduction in risk of infection.

Overall, the vaccinated group had a 61% increased risk of infection compared to the unvaccinated group (HR: 1.61 [95% CI: 0.65-4.03]). 

However, when looking specifically at the Pfizer vaccine combined with lack of natural immunity, that group’s performance was exceptionally poor.  Pfizer-vaccinated children from the age of 6 months to 4 years without prior infection were 257% (HR 3.57, 95% CI: 1.10-11.63) more likely to develop symptomatic COVID-19 compared to the children who were unvaccinated. 

This paper had 35 authors from 15 different medical institutions across the country, including the CDC and the University of Michigan.  Funny, I didn’t hear about this study in the news.  Did you?

https://pubmed.ncbi.nlm.nih.gov/39656907

/by

The VA Study

A study was done using data from the Veteran Health Administration (VHA) system collected from October 2023 through May 2024, and published in March 2025.  The title of the study was Effectiveness of the 2023-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up.  Approximately 587,000 vaccinated veterans were compared to 587,000 unvaccinated veterans. 

In the first paragraph of the Discussion section, the authors wrote, “the COVID-19 vaccine targeting the XBB.1.5 variant of Omicron was not protective against documented SARS-CoV-2 infection and had a relatively low estimated effectiveness against SARS-CoV-2-associated hospitalization (VE, 16.64%) and death (VE 26.61%).”    

Indeed, the VE was -3.26% (95% CI, -6.78% to -0.22%) against documented SARS-CoV-2 infection.  So, again – as demonstrated in the studies from the previous posts, the vaccinated group had a statistically significant higher infection rate than the unvaccinated control group.

https://pubmed.ncbi.nlm.nih.gov/39903865

/by
Copyright © 2018-2021 - Park Allergy Center, PC